Literature DB >> 35782792

Metastatic Malignant Phosphaturic Mesenchymal Tumor of Mandibular Alveolus: a Rare Case Report and Review of Literature.

Kuldeep Thakur1, Chirom Amit Singh1, Aanchal Kakkar2, Rakesh Kumar3, Atul Sharma4, Alok Thakar1.   

Abstract

Malignant phosphaturic mesenchymal tumors (PMT) of the head and neck region are extremely rare, which cause paraneoplastic syndrome characterized by hypophosphatemia and osteomalacia. We report a 48-year-old gentleman who had persistent knee and calf pain associated with weakness in lower limbs on presentation. He had hypophosphatemia and elevated FGF-23 and 68 Ga-DOTANOC PET scan showed soft tissue density mass with increased peripheral radiotracer uptake in the left mandibular alveolus and adjoining floor of the mouth, revealing the primary tumor. It also showed a non-avid, histological inconclusive nodule of 17 × 12 mm in size in the lower lobe of the right lung. The patient was treated with composite resection and bilateral level I-III neck dissection with microvascular free fibula osteocutaneous flap mandibular reconstruction. Histopathological examination showed malignant PMT with positive soft tissue margins and bilateral metastatic cervical lymphadenopathy. The patient received adjuvant radiation therapy and sequential post therapy scans showed no evidence of locoregional disease, however showed progressive functional pulmonary metastatic disease which did not respond to chemotherapy. We also made a brief review of literature of head and neck malignant PMT focusing on presentation, primary and adjuvant treatment, and response to treatment. © Indian Association of Surgical Oncology 2021.

Entities:  

Keywords:  FGF-23; Hypophosphatemia; Phosphaturic mesenchymal tumor; Tumor-induced osteomalacia

Year:  2021        PMID: 35782792      PMCID: PMC9240173          DOI: 10.1007/s13193-021-01449-8

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  16 in total

Review 1.  The expanding family of hypophosphatemic syndromes.

Authors:  Thomas O Carpenter
Journal:  J Bone Miner Metab       Date:  2011-12-14       Impact factor: 2.626

2.  A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors.

Authors:  Jodi M Carter; Bolette L Caron; Ahmet Dogan; Andrew L Folpe
Journal:  Am J Surg Pathol       Date:  2015-01       Impact factor: 6.394

3.  Malignant phosphaturic mesenchymal tumor of the larynx.

Authors:  Douglas Sidell; Chi Lai; Sunita Bhuta; Leon Barnes; Dinesh K Chhetri
Journal:  Laryngoscope       Date:  2011-06-30       Impact factor: 3.325

4.  Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis.

Authors:  Jason K Wasserman; Bibianna Purgina; Chi K Lai; Denis Gravel; Alyssa Mahaffey; Diana Bell; Simion I Chiosea
Journal:  Head Neck Pathol       Date:  2016-01-12

5.  Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour.

Authors:  Jen-Chieh Lee; Yung-Ming Jeng; Sheng-Yao Su; Chen-Tu Wu; Keh-Sung Tsai; Cheng-Han Lee; Chung-Yen Lin; Jodi M Carter; Jenq-Wen Huang; Shu-Hwa Chen; Shyang-Rong Shih; Adrián Mariño-Enríquez; Chih-Chi Chen; Andrew L Folpe; Yih-Leong Chang; Cher-Wei Liang
Journal:  J Pathol       Date:  2015-01-07       Impact factor: 7.996

6.  Varied presentation of sinonasal phosphaturic mesenchymal tumour: report of a case series with follow-up.

Authors:  Regi Kurien; Vedantam Rupa; Meera Thomas
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-16       Impact factor: 2.503

7.  Oncogenic osteomalacia: two case reports with surprisingly different outcomes.

Authors:  Roberto Seijas; Oscar Ares; Judit Sierra; Manuel Pérez-Dominguez
Journal:  Arch Orthop Trauma Surg       Date:  2009-01-06       Impact factor: 3.067

8.  Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.

Authors:  Andrew L Folpe; Julie C Fanburg-Smith; Steven D Billings; Michele Bisceglia; Franco Bertoni; Justin Y Cho; Michael J Econs; Carrie Y Inwards; Suzanne M Jan de Beur; Thomas Mentzel; Elizabeth Montgomery; Michal Michal; Markku Miettinen; Stacey E Mills; John D Reith; John X O'Connell; Andrew E Rosenberg; Brian P Rubin; Donald E Sweet; Tuyethoa N Vinh; Lester E Wold; Brett M Wehrli; Kenneth E White; Richard J Zaino; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2004-01       Impact factor: 6.394

9.  Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue.

Authors:  Naoki Uramoto; Mitsuru Furukawa; Tomokazu Yoshizaki
Journal:  Auris Nasus Larynx       Date:  2008-03-07       Impact factor: 1.863

10.  Peptide Receptor Radionuclide and Octreotide: A Novel Approach for Metastatic Tumor-Induced Osteomalacia.

Authors:  Abilash Nair; Semanti Chakraborty; Pramila Dharmshaktu; Nikhil Tandon; Yashdeep Gupta; Rajesh Khadgawat; Puthiyaveettil Khadar Jabbar; Chandra Sekhar Bal; Shipra Agarwal; Mohd Ashraf Ganie
Journal:  J Endocr Soc       Date:  2017-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.